Search - tctmd.com

Displaying 861 - 880 of 1577

Sort: Relevancy | Date

Statins Provide No Benefit in Older Adults Without CVD: ALLHAT Analysis

News Daily News

Statins Provide No Benefit in Older Adults Without CVD: ALLHAT Analysis

Michael O'Riordan

May 29, 2017

DAWN Trial May Lay Groundwork for Extending Treatment Window for Acute Stroke Therapy

News Daily News

DAWN Trial May Lay Groundwork for Extending Treatment Window for Acute Stroke Therapy

May 26, 2017

Two New Trials Buoy Outlook for PFO Closure in Patients With Cryptogenic Stroke

News Daily News

Two New Trials Buoy Outlook for PFO Closure in Patients With Cryptogenic Stroke

May 24, 2017

‘Reassuring’ Results for Watchman LAA Closure Device Seen in EWOLUTION Registry

News Daily News

‘Reassuring’ Results for Watchman LAA Closure Device Seen in EWOLUTION Registry

May 17, 2017

News Daily News

Tool May Help Select Patients for Endovascular Stroke Treatment

May 15, 2017

Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women

News Daily News

Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women

May 11, 2017

More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds

News Daily News

More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds

May 05, 2017

‘Forgotten’ Patients With Mechanical Heart Valves Undergoing PCI Pose Clinical Conundrum

News Daily News

‘Forgotten’ Patients With Mechanical Heart Valves Undergoing PCI Pose Clinical Conundrum

April 27, 2017

Benefits of FFR-Guided Complete Revascularization in STEMI May Be Limited to Most Severe Disease

News Daily News

Benefits of FFR-Guided Complete Revascularization in STEMI May Be Limited to Most Severe Disease

April 21, 2017

PROMISE Analysis Boosts Gatekeeper Role for FFRCT in Symptomatic Stable CAD

News Daily News

PROMISE Analysis Boosts Gatekeeper Role for FFRCT in Symptomatic Stable CAD

April 12, 2017

ICTUS: No Benefit at 10 Years With Early Invasive Strategy in NSTE ACS Patients

News Daily News

ICTUS: No Benefit at 10 Years With Early Invasive Strategy in NSTE ACS Patients

Michael O'Riordan

April 11, 2017

Same-Day Discharge After Elective PCI Grows More Popular but Still Not the Norm

News Daily News

Same-Day Discharge After Elective PCI Grows More Popular but Still Not the Norm

April 06, 2017

Looking Beyond Randomized Trials: Could a Wider Range of Studies Support Device Approval?

News Daily News

Looking Beyond Randomized Trials: Could a Wider Range of Studies Support Device Approval?

April 05, 2017

News Daily News

MR CLEAN: Sustained Benefit of Endovascular Therapy for Acute Ischemic Stroke

Michael O'Riordan

April 05, 2017

Using Coronary CTA to Evaluate Suspected CAD May Improve Patient Outcomes

News Daily News

Using Coronary CTA to Evaluate Suspected CAD May Improve Patient Outcomes

April 03, 2017

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

News Daily News

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

Michael O'Riordan

March 29, 2017

Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA

News Daily News

Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA

Michael O'Riordan

March 15, 2017

A Deadly Diet: Half of US Deaths From Cardiometabolic Causes Linked to Dietary Habits

News Daily News

A Deadly Diet: Half of US Deaths From Cardiometabolic Causes Linked to Dietary Habits

Michael O'Riordan

March 08, 2017

No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis

News Daily News

No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis

March 06, 2017

Length Matters: More Adverse Events With Absorb BVS at 1 Year in Long Lesions

News Daily News

Length Matters: More Adverse Events With Absorb BVS at 1 Year in Long Lesions

March 02, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.